NEW YORK, Oct. 16, 2014 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a drug development company, commenced on The Nasdaq Stock Market on October 16, 2014.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=28403
Atara is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications.
"Atara is dedicated to providing treatment and therapies for patients with current unmet medical needs," said Nelson Griggs, Executive Vice President, Listing Services, Nasdaq. "We are proud to welcome Atara to The Nasdaq Stock Market family and we look forward to supporting their growth and success in the future."
By listing with Nasdaq, Atara joins some of the world's largest and most revolutionary healthcare companies. Nasdaq has been the exchange of choice to 93 percent of healthcare companies that have listed on the U.S. markets year-to-date in 2014.
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,400 listed companies with a market value of over $8.5 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com.
The photo is also available via AP PhotoExpress.
CONTACT: MEDIA RELATIONS CONTACT: Will Briganti (646) 441-5012 email@example.com Christine Barna (646) 441-5310 Christine.Barna@nasdaq.com